CompletedNCT00223561
Official study titleA Double Blind, Placebo-Controlled Crossover Study to Determine the Effects of Methylphenidate on Driving Ability in Adult Patients With Attention-Deficit Hyperactivity Disorder
This study has finished and is no longer accepting participants.
In UtrechtADHDMedication studyAges 21–55
- Countries
- Netherlands
- Sponsor
- Utrecht Institute for Pharmaceutical Sciences
CompletedNCT05584475
Official study titleMindful Awareness Practices for ADHD (MAPs): Pilot Open Trial
This study has finished and is no longer accepting participants.
In CincinnatiADHDBehavioural studyAges 13–17
- Countries
- United States
- Sponsor
- Children's Hospital Medical Center, Cincinnati
CompletedNCT04316832
Official study titleA Randomized-Controlled Trial: the Effectiveness of a Single-session of Mindfulness Based Cognitive Training on CVC and Core Symptoms in Children and Adolescents With ADHD
This study has finished and is no longer accepting participants.
In Cluj-NapocaADHDBehavioural studyAges 6–17
- Countries
- Romania
- Sponsor
- Babes-Bolyai University
CompletedNCT02290899
This study has finished and is no longer accepting participants.
In East ProvidenceADHDObservational studyAges 10–17
- Countries
- United States
- Sponsor
- Rhode Island Hospital
CompletedNCT02630017
This study has finished and is no longer accepting participants.
Multiple locations, including Little RockADHDMedication studyAges 18–45
- Countries
- United States
- Sponsor
- University of Arkansas
WithdrawnNCT06077669
Official study titleMultimodal Brain Imaging of the Neural Effects of Methylphenidate in Children and Adolescents With ADHD
This study was withdrawn before enrollment.
In BaltimoreADHDMedication studyAges 6–18
- Countries
- United States
- Sponsor
- Johns Hopkins University
CompletedNCT04511169
Official study titleA Self-guided Internet-delivered Intervention for Adults With ADHD: Study Protocol for a Micro-randomized Trial Investigating the Use of Reminders
This study has finished and is no longer accepting participants.
In BergenADHDBehavioural studyAges 18+
- Countries
- Norway
- Sponsor
- Haukeland University Hospital
CompletedNCT03661788
Official study titleNetwork Connectivity and Inhibitory Control Under Atomoxetin Challenge- A Pharmacological 'Resting State' and 'Inhibiton Task' Study in Patients With ADHD
This study has finished and is no longer accepting participants.
In AachenADHDMedication studyAges 18–45
- Countries
- Germany
- Sponsor
- RWTH Aachen University
CompletedNCT02473419
This study has finished and is no longer accepting participants.
In New YorkADHDObservational studyAges 18–60
- Countries
- United States
- Sponsor
- Icahn School of Medicine at Mount Sinai
CompletedNCT01924429
This study has finished and is no longer accepting participants.
In New YorkADHDMedication studyAges 18–55
- Countries
- United States
- Sponsor
- Jeffrey Newcorn
CompletedNCT01819259
This study has finished and is no longer accepting participants.
In DurhamADHDMedication studyAges 18–25
- Countries
- United States
- Sponsor
- Scott Kollins, PhD
CompletedNCT06638411
This study has finished and is no longer accepting participants.
In TorontoADHDBehavioural studyAges 18–25
- Countries
- Canada
- Sponsor
- University of Toronto